<p><b>Copyright information:</b></p><p>Taken from "P-cadherin expression in breast cancer: a review"</p><p>http://breast-cancer-research.com/content/9/5/214</p><p>Breast cancer research : BCR 2007;9(5):214-214.</p><p>Published online 31 Oct 2007</p><p>PMCID:PMC2242663.</p><p></p> In normal breast, P-cadherin is only expressed by myoepithelial cells and not by luminal epithelial cells. In the low-grade arm of breast carcinomas, the majority of lesions are negative for P-cadherin expression, such as invasive lobular carcinomas (ILC), tubular carcinomas, and well differentiated ductal carcinoma (DCIS) and invasive ductal carcinomas (IDC). In the other arm, high-grade lesions are frequently positive for this cadherin, including the medullary ca...
P-cadherin is frequently over-expressed in high-grade invasive breast carcinomas and has been report...
Purpose: The claudin-low molecular subtype of breast cancer includes triple negative invasive carcin...
Purpose: P-cadherin overexpressionhas been reported in breast carcinomas,where itwas associated with...
Upregulation of N-cadherin in epithelial tumor cells has been shown to contribute to the invasive/me...
Human breast carcinomas represent a heterogeneous group of tumors diverse in behavior, outcome, and ...
Gene expression profiles of invasive breast carcinomas have identified a subgroup of tumours with wo...
International audienceAbstract Background Inflammatory breast cancer (IBC) is a distinct and aggress...
Abstract Purpose:P-cadherinoverexpressionhas been reported inbreast carcinomas, where it was asso-ci...
There were investigated 22 cases with invasive breast carcinoma from the archive material, and the i...
Introduction: The most suitable immunohistochemical criterion to identify basal-like breast carcinom...
Contains fulltext : 88839.pdf (publisher's version ) (Closed access)AIMS: Medullar...
P-cadherin, a transmembrane molecule similar to E-cadherin involved in the cell-cell adhesion, and c...
A b s t r a c t We studied the pattern of E-cadherin expression in 183 invasive carcinomas (100 duct...
Breast cancer is a heterogeneous disease, and patients are categorized into subtypes according to ge...
Purpose: To determine whether E-cadherin loss causes nonlobular cancers (NLCs) detected at mammograp...
P-cadherin is frequently over-expressed in high-grade invasive breast carcinomas and has been report...
Purpose: The claudin-low molecular subtype of breast cancer includes triple negative invasive carcin...
Purpose: P-cadherin overexpressionhas been reported in breast carcinomas,where itwas associated with...
Upregulation of N-cadherin in epithelial tumor cells has been shown to contribute to the invasive/me...
Human breast carcinomas represent a heterogeneous group of tumors diverse in behavior, outcome, and ...
Gene expression profiles of invasive breast carcinomas have identified a subgroup of tumours with wo...
International audienceAbstract Background Inflammatory breast cancer (IBC) is a distinct and aggress...
Abstract Purpose:P-cadherinoverexpressionhas been reported inbreast carcinomas, where it was asso-ci...
There were investigated 22 cases with invasive breast carcinoma from the archive material, and the i...
Introduction: The most suitable immunohistochemical criterion to identify basal-like breast carcinom...
Contains fulltext : 88839.pdf (publisher's version ) (Closed access)AIMS: Medullar...
P-cadherin, a transmembrane molecule similar to E-cadherin involved in the cell-cell adhesion, and c...
A b s t r a c t We studied the pattern of E-cadherin expression in 183 invasive carcinomas (100 duct...
Breast cancer is a heterogeneous disease, and patients are categorized into subtypes according to ge...
Purpose: To determine whether E-cadherin loss causes nonlobular cancers (NLCs) detected at mammograp...
P-cadherin is frequently over-expressed in high-grade invasive breast carcinomas and has been report...
Purpose: The claudin-low molecular subtype of breast cancer includes triple negative invasive carcin...
Purpose: P-cadherin overexpressionhas been reported in breast carcinomas,where itwas associated with...